Issue 5/2011
Content (14 Articles)
Review of the Randomized Evaluation of Long-Term Anticoagulation Therapy (RE-LY) Trial: Warfarin Versus Dabigatran
- Clinical Trial Report
Christopher Ingelmo, Oussama Wazni
The Use of Drug-Eluting Stents Versus Bypass Surgery for Left Main Coronary Artery Disease
- Clinical Trial Report
Eric L. Wallace, David J. Moliterno
New Paradigms in the Prevention of Sudden Cardiac Arrest and Heart Failure Treatment
Mustafa Dohadwala, N. A. Mark Estes III, Mark S. Link
Update on the Management of Atrial Fibrillation: Anticoagulation and Medical Therapy
Shueh Hao Lim, Hugh Calkins, Sunil K. Sinha
Atrial Fibrillation: Update on Ablation Strategies and Technology
Prasanna K. Challa, Moussa Mansour
Utilizing Risk Scores in Determining the Optimal Revascularization Strategy for Complex Coronary Artery Disease
- Open Access
Vasim Farooq, Salvatore Brugaletta, Patrick W. Serruys
Revascularization for Unprotected Left Main Coronary Artery Disease: An Evolution in Clinical Decision Making
- Open Access
David E. Kandzari, John A. Ormiston
Percutaneous Coronary Interventions in Facilities Without Cardiac Surgery on Site
Yuri B. Pride, C. Michael Gibson
Genotypic and Phenotypic Assessment of Platelet Function and Response to P2Y12 Antagonists
Axel de Labriolle, Jean Philippe Doazan, Gilles Lemesle, Laurent Bonello
Thienopyridine-Associated Drug-Drug Interactions: Pharmacologic Mechanisms and Clinical Relevance
Jean-Sébastien Hulot, Jean-Philippe Collet, Gilles Montalescot
Bare-Metal Stents Versus Drug-Eluting Stents for Primary Angioplasty: Long-Term Outcome
Emilio Di Lorenzo, Giannignazio Carbone, Luigi Sauro, Alfredo Casafina, Michele Capasso, Rosario Sauro